Daewoong Pharmaceutical
↗Seoul, South Korea
Daewoong Pharmaceutical is a leading South Korean global healthcare group founded in 1945. The company specializes in the development, manufacturing, and commercialization of both prescription and over-the-counter medicines, with a strong emphasis on innovative R&D. It is best known for its botulinum toxin product, Nabota (marketed as Jeuveau in the US), and its recent breakthroughs in gastrointestinal and metabolic disease treatments.
The company operates a robust global network with subsidiaries in eight countries, including the US, China, and Indonesia. Daewoong is currently pivoting toward a 'Global Big Pharma' strategy, focusing on first-in-class and best-in-class drug development in areas such as fibrosis, autoimmune diseases, and oncology, while leveraging its proprietary AI-driven drug discovery platform.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Biotherapeutics and Small Molecules
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B-$1.5B
Founded:1945
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:National Pension Service of Korea, Daewoong Co., Ltd. (Holding Company)
STOCK
Exchange:KRX
Ticker:069620
Market Cap:$1.2B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Fexuclue, Envlo, Nabota)
Modalities:Small molecule, Botulinum Toxin, Cell therapy, Peptide
Active Trials:24
Trial Phases:Phase 1: 10 | Phase 2: 6 | Phase 3: 8
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Parent Company:Daewoong Co., Ltd.
Subsidiaries:Daewoong America Inc., PT Daewoong Infion (Indonesia), Daewoong Biologics Indonesia
Key Partnerships:Evolus (US partner for Nabota/Jeuveau), CS Pharmaceuticals (Bersiporocin licensing in Greater China), Zydus Lifesciences (Generic drug collaboration)
COMPETITION
Position:Leader
Competitors:HK inno.N, Medytox, Hugel, Takeda, Celltrion
LEADERSHIP
Key Executives:
Seng-ho Jeon - CEO
Chang-jae Lee - CEO
Scientific Founders:Young-hwan Yoon
Board Members:Seng-ho Jeon, Chang-jae Lee, Jong-wook Lee
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Daewoong Pharmaceutical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.